Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury - Wikidata - wikimedia - TriplyDB

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

http://www.wikidata.org/entity/Q30423561

about

Effects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin.Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice.Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy Inflammatory cytokines in diabetic nephropathy.Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy.Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq Expression and function of CCL2/CCR2 in rat micturition reflexes and somatic sensitivity with urinary bladder inflammation Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.Meprin A impairs epithelial barrier function, enhances monocyte migration, and cleaves the tight junction protein occludin.Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism Macrophages directly mediate diabetic renal injury.Emerging roles of hematopoietic cells in the pathobiology of diabetic complications.Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options.Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.Fetuin-A aggravates lipotoxicity in podocytes via interleukin-1 signaling.Developing Treatments for Chronic Kidney Disease in the 21st Century.The NLRP3 inflammasome in kidney disease and autoimmunity.The next generation of therapeutics for chronic kidney disease Inflammasome Activation in Chronic Glomerular Diseases.Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.Monocyte-Derived Dendritic Cells Impair Early Graft Function Following Allogeneic Islet Transplantation.Integrative Analysis of miRNA and mRNA Expression Profiles in Calcium Oxalate Nephrolithiasis Rat Model.Chemokines in homeostasis and diseases.Overexpression of heart-type fatty acid binding protein enhances fatty acid-induced podocyte injury.Distinct roles of arginases 1 and 2 in diabetic nephropathy.Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.Protective effects of leflunomide on renal lesions in a rat model if diabetic nephropathy.Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease.

P2860

Q28080888-71C86437-B1AE-4A20-8AEC-6AF70B2E5074 Q33725787-91693E2F-936A-4EFE-9E45-9BED1199EC78 Q33825220-95BC14DE-327A-4E8E-BE39-70577F32ACCC Q34836376-13CE9EAD-593A-4755-920B-24A507A59E47 Q35133177-B47905B3-433D-476B-8FDE-F9A8980EB33A Q35710293-B4F757C8-3E7A-425F-96A7-BE4828CAA04D Q36017619-378FE740-3EC8-4621-85A4-1577203E6F7D Q36153911-99039557-2601-4FAA-878C-A99E7627E670 Q36195357-B451A430-77B2-48B5-942F-FFC3AAE10022 Q37051472-48C4AAF9-AFF6-462F-B1F1-500EE3FC2100 Q37071386-38E8CACB-CD73-4CCC-A352-934108C35F2C Q37142513-E431CC68-07F1-49A5-854A-44DA986766C7 Q37142636-5F083337-881B-422D-9B8E-08EAB9A8AEAD Q37198831-C5192CDC-14F5-419A-9427-F720C16D52DE Q37440181-78213B02-0AC6-4627-9432-0608DE9E8813 Q37684896-9B1A1C46-DE73-4CD3-B4BB-352AC421BEC6 Q38087529-0CDD1503-8616-424C-8A2F-82A3D1953F76 Q38255902-E44DE583-F780-4145-B5D2-567A36C3C7E2 Q38758052-28B4BE18-5E3F-4FF4-8064-77461D0F1948 Q38781550-5DA41911-48B0-43D4-AC39-78F8E887E244 Q38787339-32EC3640-05D8-4FF4-B7B0-04E021C3CAE7 Q38845590-A187B01F-B803-43B2-B80B-0FEE35694444 Q38931056-9B5E278B-4D37-4B27-BE3B-B35D0CD2736B Q38936622-BEA31F91-5821-4DFB-B033-9048D021086B Q40271425-2957FDF2-0B33-481D-8102-498F86AC312B Q41559116-84852A3E-DAD6-4791-9957-CE9F40F5E149 Q45232179-41931542-B509-427D-ACB0-FFF0BBBBDE8C Q47161249-173CB158-39D2-4049-A44E-60B217AD7A3A Q48119451-4D04CA7F-05BC-49E4-96BA-C1C8143A0873 Q49634148-8F4F9283-E2D8-4A4F-BE12-37F57C3A070C Q50053918-F3AC7D66-91F1-4146-A4C4-2C83EE96F010 Q51033386-82C8A8CF-AFDF-427A-AD3D-076E5A380A88 Q51287276-8B1D4341-3DC1-4C8B-9A0B-372AB4281F98 Q53296448-F00D396D-4312-4D10-B51D-882720E7B43A Q55312504-F9F29BBB-09F9-4C6A-A8DB-550A3201F559

P2860

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

http://www.wikidata.org/entity/Q30423561

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

@ast

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

@en

type

label

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

@ast

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

@en

prefLabel

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

@ast

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

@en

P1433

Q30423561-DFC1DDD5-9233-433F-845D-8A3B86153FE6

P1476

Q30423561-AEB49797-048C-4BBF-BE9F-ECE59E1A1859

P2093

Q30423561-00E7F9A5-90F1-4806-969B-96F77C0EC8D8

Q30423561-1C845293-6CD8-4E17-987D-40C53F084B72

Q30423561-58AAA0B7-1AF0-406D-80B6-13B966814449

Q30423561-C7DFEB6D-6F86-4E10-BD08-739435DEF86B

Q30423561-FE9CD1FF-7EBA-486A-AF53-E971323DE2B3

P2860

Q30423561-0070B08A-C63C-4D04-84CC-6628DC8FA0BC

Q30423561-01115FA7-D1A0-4D7A-902C-1645560AD47D

Q30423561-0336CBF5-3218-43C5-9B37-D695A5DAAF9D

Q30423561-0340817C-4D39-477C-A169-BBEAE1FA42F8

Q30423561-05F3AA28-8504-4D16-AE5F-2AF49FF8824C

Q30423561-084CECCE-A304-45AE-8997-E6C3EEA5D085

Q30423561-1E4D3D6C-FE84-4A5E-9076-AC5909A8B44E

Q30423561-21DDE22B-AF5A-4D3B-A399-A19A82090084

Q30423561-22FC7395-B5D9-4E61-8AFA-5B1A0C6FA966

Q30423561-2C9AE688-E7D9-4B8C-B341-EA5192CF0A61

P304

Q30423561-DEA4C669-7F25-4FC3-A460-42E64B78F6E8

P31

Q30423561-8AECFF10-92BF-4457-96EB-6768AB2FC2D9

P356

Q30423561-440C7DA4-4C00-4C35-BCC5-E93E0003F003

P433

Q30423561-C3347EF3-9755-4072-8924-92ED624DD188

P478

Q30423561-8847D907-6ABF-4406-A118-D223D284009D

P50

Q30423561-16A5E805-C481-4349-BE9A-C93F3BB423D1

P577

Q30423561-9EAF0A93-D47D-4EBB-B596-5D15671756C2

P698

Q30423561-3BAD8A7E-DFA9-4B2C-8C28-C1E493817A2E

P921

Q30423561-B23B565A-51C5-4EF6-B21F-A073DD7E8543

P932

Q30423561-08BCA203-72D3-4BCC-8F78-DC3102AB4E58

P356

AJPRENAL.00332.2011

P1433

American Journal of Physiology - Renal Physiology

P1476

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

@en

P2093

Alaa S Awad

http://www.w3.org/2001/XMLSchema#string

Gilbert R Kinsey

http://www.w3.org/2001/XMLSchema#string

Konstantine Khutsishvili

http://www.w3.org/2001/XMLSchema#string

Ting Gao

http://www.w3.org/2001/XMLSchema#string

W Kline Bolton

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails

Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice

Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats.

Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.

Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury.

Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.

Mouse models of diabetic nephropathy.

Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis

Blockade of CCR2 ameliorates progressive fibrosis in kidney.

P304

F1358-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00332.2011

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

301

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21880831

http://www.w3.org/2001/XMLSchema#string

P921

P932

3233863

http://www.w3.org/2001/XMLSchema#string